Merck & Co. 19 may 2026 Merck inks Keytruda supply pact to support Exelixis cancer trial - Fierce Biotech
FierceBiotech 19 may 2026 Lauxera Capital Partners raises a hefty €520M for health, medtech companies
FierceBiotech 19 may 2026 Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial